About US
Contact us
-
Bristol Myers, Exelixis scored a kidney cancer combo win. But is there room for their duo on the market?Bristol Myers Squibb and Exelixis have a potential kidney cancer contender on their hands—but they’ll have to meet a “high bar” to gain traction in the crowded field, one analyst says. A combination2020/4/21
-
Eyeing COVID-19 shortages, FDA unleashes compounded drugs to treat hospital patientsAfter a series of high-profilefailures in the early 2010s, the compounding pharmacy industry took its share ofbody blows from an FDA looking to impose its will. Now, after years of lockdown, the FDA2020/4/20
-
Alexion, following clues from early tests, preps phase 3 study of Ultomiris in severe COVID-19For about two months, Alexion has been exploring whether itsSoliris—used to treat several rare diseases—might holdpromise in treating patients with severeCOVID-19, the illness caused by the novel cor2020/4/20
-
FiercePharmaPolitics—With 'LIBERATE' tweets, Trump seems to endorse lockdown protestsWelcome to theFiercePharmapolitical roundup, where each Monday we’ll highlight political developments that could affect the pharmaceutical industry. As theU.S.economic toll from COVID-19 lockdowns co2020/4/17
-
Seattle Genetics breaks into breast cancer with new approval TukysaSeattle Genetics is officially ready to make its first foray into the breast cancer field, thanks to some "stunning" data and a brand-new FDA approval that came four months ahead of schedule. The age2020/4/16
-
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharmaBiopharma companies all vow to help patients, but how do they fare in creating healthy workplace environments for their employees? Roche’s Genentech, Novo Nordisk and AbbVie ranked as the top 3 onFor2020/4/15
-
Novartis forced to face claims it fired employee for raising Gilenya kickback scheme concernsDogged by whistleblowerkickback claims over its multiple sclerosis med Gilenya for years, Novartis has run off a recent string of court wins to escape the allegations. But in one New Jersey suit, Nov2020/4/14
-
Which pharma companies are the most innovative? Roche, AstraZeneca top the listThe continued prosperity of a biopharma company is dependent on its ability to keep churning out breakthrough new drugs and turning them into commercial successes backed by a growing body of clinical2020/4/13
-
Pfizer scores FDA nod for Braftovi duo in colon cancer as investors await more lucrative tripletWhen Pfizer shelled out $11.4 billion for Array BioPharma last year, it pointed to early data showing that Array’s BRAF inhibitor Braftovi, its anti-MEK drug Mektovi and the EGFR blocker Erbitux coul2020/4/13
-
Pfizer, Merck KGaA's Bavencio eyes speedy entry into untapped bladder cancer fieldPfizer and Merck KGaA’s Bavencio is heading toward a piece of the crowded bladder cancer market that it can call its own. The drug hasnabbedthe FDA’s priority review designation as a treatment for bl2020/3/27